Mice Model Market size to hit $6.9 Billion by 2035 | Top companies include Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences, Janvier Labs

Market Outlook and Forecast

The mice model market plays a foundational role in modern biomedical research, drug discovery, toxicology studies, and translational medicine. Mice models are indispensable tools for understanding disease mechanisms, evaluating therapeutic efficacy, and advancing personalized medicine. Their genetic similarity to humans, short life cycles, and adaptability to genetic manipulation have made them the most widely used mammalian model in life sciences research.

In 2025, the global mice model market is valued at USD 2.5 billion. With rising investments in pharmaceutical R&D, increasing prevalence of chronic and genetic diseases, and rapid expansion of precision medicine, the market is projected to reach USD 6.9 billion by 2035, registering a CAGR of 10.5% during 2026-2035. Growth is further reinforced by the expanding use of mice models in oncology, immunology, neuroscience, and metabolic disorder research.

The market is transitioning from conventional inbreds strains toward highly sophisticated genetically engineered models, including transgenic, knockout, knock-in, and humanized mice. These advanced models offer higher predictive accuracy and improved clinical relevance, enabling researchers to better replicate human disease pathways and treatment responses.

➤ Request Free Sample PDF Report @ https://www.researchnester.com/sample-request-8337

Regional Performance Highlights

North America leads the mice model market and is expected to account for 41.8% share by 2035. The region's dominance is supported by strong federal and private funding for biomedical research, a robust pharmaceutical and biotechnology ecosystem, and the presence of leading academic research institutions. The United States remains the largest contributor, with mice models extensively used in oncology drug pipelines, immunotherapy research, and gene therapy development.

Europe represents a mature and innovation-driven market, underpinned by advanced life sciences infrastructure and supportive regulatory frameworks for ethical animal research. Countries such as Germany, the U.K., France, and the Netherlands are key hubs for preclinical research. European research organizations are increasingly adopting standardized and ethically optimized mice models to comply with the 3Rs principle-Replacement, Reduction, and Refinement-while maintaining scientific rigor.

Asia Pacific is emerging as a high-growth region, registering a CAGR of 9.2% during 2026-2035. Growth is fueled by rising government investments in biomedical research, expanding pharmaceutical manufacturing, and increasing participation in global clinical research. China, Japan, South Korea, and India are rapidly strengthening their preclinical research capabilities, with local CROs and academic institutes driving demand for advanced mice models.

➤ Gain access to expanded insights on competitive strategies, market size, and regional analysis. View our Mice Model Market Report Overview here: https://www.researchnester.com/reports/mice-model-market/8337

Market Segmentation

By technology, the genetically engineered mice segment is projected to hold 55.4% share by 2035, reflecting its critical role in disease modeling and target validation. Technologies such as CRISPR/Cas9 gene editing have significantly reduced development timelines and costs, enabling rapid creation of customized disease-specific models. These models are extensively used in oncology, autoimmune disorders, rare diseases, and infectious disease research.

From a type perspective, inbreds mice, knockout mice, transgenic mice, and humanized mice represent the most widely used categories. Humanized mice are gaining particular traction due to their ability to replicate human immune responses, making them invaluable for immuno-oncology, vaccine development, and antibody testing. Pharmaceutical companies and CROs increasingly rely on these models to de-risk clinical trials and improve translational success rates.

➤ Explore the complete Mice Model Market forecast and regional insights in our detailed report. Download our sample report here → https://www.researchnester.com/sample-request-8337

Top Market Trends

1. Rapid Adoption of CRISPR-Based Gene Editing

CRISPR/Cas9 technology is revolutionizing the mice model market by enabling faster, more precise genetic modifications. Researchers can now generate complex multi-gene models with unprecedented efficiency. This has accelerated disease modeling for cancer, neurodegenerative disorders, and inherited genetic conditions. Leading research institutes and CROs are increasingly integrating CRISPR platforms into their preclinical workflows to meet growing demand for customized models.

2. Rising Demand for Humanized Mice in Immunology and Oncology

Humanized mice models are becoming a cornerstone of immunology and oncology research. These models allow for the study of human immune system interactions within a living organism, significantly improving the predictive value of preclinical studies. The surge in immunotherapies, including CAR-T cell therapies and immune checkpoint inhibitors, is driving strong demand for humanized mice across pharmaceutical pipelines.

3. Expansion of Contract Research Organizations (CROs)

Pharmaceutical and biotech companies are increasingly outsourcing preclinical studies to CROs to reduce costs and accelerate development timelines. This trend is boosting demand for standardized, high-quality mice models across toxicology, pharmacology, and efficacy testing. CROs are investing heavily in breeding facilities, bioinformatics integration, and automated phenotyping systems to enhance scalability and reproducibility.

4. Ethical Optimization and Digital Monitoring Technologies

Ethical considerations are reshaping the mice model market, with increased focus on animal welfare and regulatory compliance. Digital monitoring tools, AI-driven behavioral analysis, and automated imaging technologies are being deployed to minimize animal usage while maximizing data output. These innovations support regulatory requirements and improve study efficiency without compromising scientific outcomes.

➤ Unlock detailed analysis of key market trends transforming hybrid mobility. Get your sample report → https://www.researchnester.com/sample-request-8337

Recent Company Developments

The mice model market is highly competitive and innovation-driven, with companies focusing on advanced genetic technologies, strategic collaborations, and global expansion.

Key developments from the last 12 months include:

1. The Jackson Laboratory - Expanded its genetically engineered mice portfolio, introducing new oncology and rare disease models tailored for precision medicine research.

2. Charles River Laboratories - Invested in advanced breeding and gene-editing facilities to support growing demand from pharmaceutical and biotech clients.

3. Taconic Biosciences - Launched next-generation humanized mice models designed for immuno-oncology and inflammatory disease research.

4. Envigo (Inotiv) - Strengthened its preclinical services through infrastructure expansion and enhanced genetic monitoring capabilities.

5. Crown Bioscience - Expanded its translational oncology platform with new patient-derived xenograft (PDX) and humanized mouse models.

6. Janvier Labs - Focused on standardized inbreds and knockout mice strains aligned with European regulatory and ethical standards.

➤ Request Free Sample PDF Report @ https://www.researchnester.com/sample-request-8337

Related News -
https://www.linkedin.com/pulse/medical-power-supplies-market-size-reach-42-billion-2035-shirole-fyytc
https://www.linkedin.com/pulse/can-advanced-technologies-redefine-future-cellulite-market-shirole-okkoc

Contact Data

AJ Daniel
Corporate Sales, USA
Research Nester
77 Water Street 8th Floor, New York, 10005
Email: info@researchnester.com
USA Phone: +1 646 586 9123
Europe Phone: +44 203 608 5919

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

This release was published on openPR.